With all six samples taken together, we found that peptides predicted to bind to lost alleles had increased peptide intensity in tumor samples compared to normal samples for HLA-A, HLA-B and HLA-C alleles (Fig. 4b). The gene discussed is HLA-A; the disease is neoplasm.